#karnataka fda

1 story

#counterfeit drugs #drug licenses #patient safety #pfizer india #securities

Pfizer India defends patient safety after Karnataka FDA crackdown
Pfizer India says patient safety remains top priority after Karnataka FDA cancels 16 drug licenses for counterfeit medicines
The Economic Times · 1m